AbbVie : ABBV

All AbbVie Articles

623 Articles

Jon C. Ogg | Oct 2, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

courtesy of Jon OggStocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one…

Lee Jackson | Oct 2, 2017 at 8:25 AM EDT

5 Stocks to Buy That Are Much Cheaper Than the S&P 500

While it seems everything is fully priced, the good news for investors is that there is still a plethora of…

Chris Lange | Sep 28, 2017 at 12:45 PM EDT

AbbVie and Amgen Reach Global Resolution of Humira

AbbVie shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 25, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

The top analyst upgrades, downgrades and other research calls from Monday include Albermarle, Blue Apron, Box, Dish Network, GM, Transocean…

Jon C. Ogg | Sep 15, 2017 at 9:10 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle,…

Chris Lange | Sep 13, 2017 at 8:40 AM EDT

Major Pharma Short Interest Surges

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 7, 2017 at 4:08 PM EDT

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was a mixed day for the U.S. broad markets with all major indices starting off positive, but quickly souring…

Chris Lange | Aug 25, 2017 at 9:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 10, 2017 at 8:40 AM EDT

Short Sellers Hike Bets in Major Pharma

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 2, 2017 at 1:20 PM EDT

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

A blockbuster drug is about to get a chance to have even higher sales, as the FDA has expanded its…

Chris Lange | Jul 28, 2017 at 11:10 AM EDT

AbbVie Slips Despite Q2 Earnings Beat

AbbVie reported better-than-expected second-quarter financial results before the markets opened on Friday.

Chris Lange | Jul 26, 2017 at 8:55 AM EDT

Major Pharma Short Interest Takes a Big Step Back

The July 14 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jul 19, 2017 at 9:42 AM EDT

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the…

Chris Lange | Jul 13, 2017 at 9:20 AM EDT

Major Pharma Short Sellers Become More Selective

The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 25 26 27 28 29 … 42

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

5 Stocks to Buy That Are Much Cheaper Than the S&P 500

AbbVie and Amgen Reach Global Resolution of Humira

Major Pharma Short Interest Piles On

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

Thursday’s Biggest Winners and Losers in the S&P 500

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

AbbVie Slips Despite Q2 Earnings Beat

Major Pharma Short Interest Takes a Big Step Back

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

Major Pharma Short Sellers Become More Selective

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

3 Boring but Brilliant Stocks to Buy in August

XRP Price Prediction: Analyst Says XRP Will Hit $27 by October 2026

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

Social Isolation Can Quietly Wreck a Retiree's Health. Original Medicare Won't Spend a Cent to Prevent It.

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

3 Boring but Brilliant Stocks to Buy in August

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

5 Stocks to Buy That Are Much Cheaper Than the S&P 500

AbbVie and Amgen Reach Global Resolution of Humira

Major Pharma Short Interest Piles On

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

Thursday’s Biggest Winners and Losers in the S&P 500

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Blockbuster Drug Imbruvica Gets Expanded FDA Approval for Chronic Graft Versus Host Disease

AbbVie Slips Despite Q2 Earnings Beat

Major Pharma Short Interest Takes a Big Step Back

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

Major Pharma Short Sellers Become More Selective

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

3 Boring but Brilliant Stocks to Buy in August

XRP Price Prediction: Analyst Says XRP Will Hit $27 by October 2026

Featured Reads

Have a $450,000 401(k) and Want to Donate Before Year-End? Make Sure You Do This Now

Social Isolation Can Quietly Wreck a Retiree's Health. Original Medicare Won't Spend a Cent to Prevent It.